DasÃ-Navarro, N.; Lozano, M.; Llop, S.; Esplugues, A.; Cimbalo, A.; Font, G.; Manyes, L.; Mañes, J.; Vila-Donat, P.
Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine. Toxins 2022, 14, 651.
https://doi.org/10.3390/toxins14100651
AMA Style
DasÃ-Navarro N, Lozano M, Llop S, Esplugues A, Cimbalo A, Font G, Manyes L, Mañes J, Vila-Donat P.
Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine. Toxins. 2022; 14(10):651.
https://doi.org/10.3390/toxins14100651
Chicago/Turabian Style
DasÃ-Navarro, Nuria, Manuel Lozano, Sabrina Llop, Ana Esplugues, Alessandra Cimbalo, Guillermina Font, Lara Manyes, Jordi Mañes, and Pilar Vila-Donat.
2022. "Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine" Toxins 14, no. 10: 651.
https://doi.org/10.3390/toxins14100651
APA Style
DasÃ-Navarro, N., Lozano, M., Llop, S., Esplugues, A., Cimbalo, A., Font, G., Manyes, L., Mañes, J., & Vila-Donat, P.
(2022). Development and Validation of LC-Q-TOF-MS Methodology to Determine Mycotoxin Biomarkers in Human Urine. Toxins, 14(10), 651.
https://doi.org/10.3390/toxins14100651